Structure and Functions of an IL-1 inhibitor found at inflammatory site in rabbit.
兔炎症部位发现的 IL-1 抑制剂的结构和功能。
基本信息
- 批准号:03454172
- 负责人:
- 金额:$ 4.1万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1991
- 资助国家:日本
- 起止时间:1991 至 1992
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A rabbit interleukin-1 (IL-1) inhibitor in inflammatory peritoneal exudate cells was purified to apparent homogeneity. This inhibitor was extracted from exudate cells of the 24-hr stage of peritoneal inflammation and purified using isoelectrofocusing (IEF), gel filtration, followed in this order by high-performance liquid chromatography steps with hydroxylapatite and anionic ion exchanger. The purified factor showed a single band on silver-stained SDS-PAGE. This molecule of MW 19 kD and pI 5.5 inhibited the binding of both IL-1alpha and beta to receptors on a thymoma cell line, EL-4 and a B-cell line, 70Z/3. We determined its primary structure by a combination of peptide chemistry and molecular cloning. The inhibitor was synthesized as a precursor composed of 177 amino acids and was processed to a mature molecule of 143 amino acids. The N-terminal amino acid of the mature inhibitor was N-acetyl-methionine residue. The deduced amino acid sequence of the inhibitor showed a 77% homology t … More o the human IL-1 receptor antagonist (IL-1ra) and essentially the same mode of action as seen with human IL-1ra. We consider the this inhibitor is a rabbit counterpart of human IL-1ra, although there are differences with respect to the molecular structure; the N-terminus of the mature rabbit IL-1ra at a position of nine amino acids downstream from that of human IL-1ra.Further, we made a recombinant rabbit IL-1ra (rrIL-1ra) expressed in E. coli. Using the rrIL-1ra, we also made a sheep anti-serum and developed an ELISA system for the rabbit IL-1ra. The rrIL-1ra was purified using DEAE-cellulose and Sephadex G-75, in a conventional chromatography system, followed by a linear NaCl gradient-elution of DEAE-cellulose in an FPLC system. Its specific biologic activity was almost the same as the authentic natural product. Using the above described tools, we examined the generation of IL-1ra during the course of LPS-arthritis in rabbits. Production of IL-1ra peaked at 9 hr (196.7 ng/joint) and the amount was 180-200 fold molar excess of IL-1 found at the lesion, and a large amount of IL-1ra was sustained for one week. The LPS-induced arthritis was strongly suppressed by intra-articular injection of 10 mug of IL-1ra when the severity of arthritis was monitored by the infiltration of leukocytes and destruction of articular cartilage. Then, we concluded that IL-1ra play an regulatory role in inflammation and may become a potent anti-inflammatory agent. Less
兔炎症性腹膜渗出细胞中的白细胞介素-1 (IL-1)抑制剂被纯化到明显的均匀性。该抑制剂从腹膜炎症24小时期的渗出细胞中提取,采用等电聚焦(IEF)、凝胶过滤纯化,然后用羟基磷灰石和阴离子交换剂进行高效液相色谱纯化。纯化后的因子在SDS-PAGE银染色上呈单条带。在胸腺瘤细胞系EL-4和b细胞系70Z/3上,mw19kd和pi5.5分子抑制il -1 α和β与受体的结合。我们通过多肽化学和分子克隆相结合的方法确定了其一级结构。该抑制剂是由177个氨基酸组成的前体合成的,经过加工得到143个氨基酸的成熟分子。成熟抑制剂的n端氨基酸为n -乙酰蛋氨酸残基。该抑制剂的氨基酸序列与人IL-1受体拮抗剂(IL-1ra)有77%的同源性,其作用方式与人IL-1ra基本相同。我们认为这种抑制剂是人类IL-1ra的兔子对应物,尽管在分子结构方面存在差异;成熟兔IL-1ra的n端位于人类IL-1ra下游9个氨基酸的位置。进一步,我们制作了在大肠杆菌中表达的重组兔IL-1ra (rrIL-1ra)。我们还利用ril -1ra制备了绵羊抗血清,并建立了兔IL-1ra的ELISA系统。在常规色谱系统中使用deae -纤维素和Sephadex G-75纯化rrIL-1ra,然后在FPLC系统中使用deae -纤维素线性NaCl梯度洗脱。其比生物活性与正品天然产物基本一致。使用上述工具,我们检测了兔lps关节炎过程中IL-1ra的产生。IL-1ra的产生在9小时达到峰值(196.7 ng/关节),病变处IL-1的量为180-200倍摩尔过量,大量IL-1ra持续一周。通过白细胞浸润和关节软骨破坏监测关节炎的严重程度,关节内注射10杯IL-1ra可明显抑制lps诱导的关节炎。因此,我们得出结论,IL-1ra在炎症中起调节作用,可能成为一种有效的抗炎剂。少
项目成果
期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ohkawara S,Matsukawa A and Yoshinaga M: "Neutrophils as the major producer of interleukin 1 and its inhibitor at the inflammatory site in rabbits." Archiv.Immunol.Therap.Exp.40. 11-16 (1992)
Ohkawara S、Matsukawa A 和 Yoshinaga M:“中性粒细胞是兔子炎症部位白细胞介素 1 及其抑制剂的主要产生者。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
F.Goto,K.Goto.,T.Miyata,S.Ohkawara,T.Takao,S.Mori,S.Iwanaga,M.Yoshinaga: "Interleukin 1 receptor antagonist in inflammatory exudate cells of rabbits.Production,purification and determination of primary structure." Immunology.
F.Goto,K.Goto.,T.Miyata,S.Ohkawara,T.Takao,S.Mori,S.Iwanaga,M.Yoshinaga:“兔炎症渗出细胞中白细胞介素1受体拮抗剂。生产、纯化和测定
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsukawa A, Ohkawara S and Yoshinaga M: Hokkaido University Press. Intractable vasculitis syndromes, 131-138 (1993)
松川 A、大河原 S 和吉永 M:北海道大学出版社。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Sagara,S.Mori,S.Ohkawara,F.Goto,K.Takagi,M.Yoshinaga: "A limited role of ILー1 in immune enlancewent by acijavants." Immunology. 71. 251-257 (1990)
T. Sagara、S. Mori、S. Ohkawara、F. Goto、K. Takagi、M. Yoshinaga:“IL-1 在免疫学中的有限作用”71. 251-257 (1990)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
松川 昭博、吉永 秀: "Annual Review免疫" 中外医学社, 110-117 (1992)
Akihiro Matsukawa,Hide Yoshinaga:“免疫学年度评论”Chugai Igakusha,110-117(1992)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHINAGA Masaru其他文献
YOSHINAGA Masaru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHINAGA Masaru', 18)}}的其他基金
Mechanism of delayed phase of increased vascular permeabitity in acute inflammation
急性炎症血管通透性增加延迟期的机制
- 批准号:
09470065 - 财政年份:1997
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Determination of cytokines involved in initiation of acute inflammation.
测定参与急性炎症引发的细胞因子。
- 批准号:
07457060 - 财政年份:1995
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of inflammatory response by an inhibitory cytokine in a mode of inhiditory cybemetics
抑制性细胞因子在抑制性控制学模式下调节炎症反应
- 批准号:
05454182 - 财政年份:1993
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
A New Aspect of Neutrophil Function Dependent on Their Protein Synthesis.
中性粒细胞功能依赖于其蛋白质合成的新方面。
- 批准号:
01480166 - 财政年份:1989
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Polymorphonuclear leukocytes as an inflammatory hormone-producing argan.
多形核白细胞作为产生炎症激素的摩洛哥坚果。
- 批准号:
62480143 - 财政年份:1987
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
IL-25 exacerbates autoimmune aortitis in IL-1 receptor antagonist-deficient mice
IL-25 加剧 IL-1 受体拮抗剂缺陷小鼠的自身免疫性主动脉炎
- 批准号:
16K10666 - 财政年份:2016
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of an effective therapy for fulminant hepatic failure using IL-1 receptor antagonist
建立使用IL-1受体拮抗剂治疗暴发性肝衰竭的有效疗法
- 批准号:
19790957 - 财政年份:2007
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
IL-1 RECEPTOR ANTAGONIST GENE THERAPY FOR THE TREATMENT OF INFLAMMATORY DISEASES
用于治疗炎症性疾病的 IL-1 受体拮抗剂基因疗法
- 批准号:
6105635 - 财政年份:1999
- 资助金额:
$ 4.1万 - 项目类别:
IL-1 RECEPTOR ANTAGONIST GENE THERAPY FOR THE TREATMENT OF INFLAMMATORY DISEASES
用于治疗炎症性疾病的 IL-1 受体拮抗剂基因疗法
- 批准号:
6270779 - 财政年份:1998
- 资助金额:
$ 4.1万 - 项目类别:
IL-1 RECEPTOR ANTAGONIST GENE THERAPY FOR THE TREATMENT OF INFLAMMATORY DISEASES
用于治疗炎症性疾病的 IL-1 受体拮抗剂基因疗法
- 批准号:
6239171 - 财政年份:1997
- 资助金额:
$ 4.1万 - 项目类别:
REGULATION OF IL-1 AND IL-1 RECEPTOR ANTAGONIST EXPRESSION BY IL-4
IL-4对IL-1和IL-1受体拮抗剂表达的调节
- 批准号:
3792490 - 财政年份:
- 资助金额:
$ 4.1万 - 项目类别:
IL-1 RECEPTOR ANTAGONIST GENE THERAPY FOR THE TREATMENT OF INFLAMMATORY DISEASES
用于治疗炎症性疾病的 IL-1 受体拮抗剂基因疗法
- 批准号:
5210857 - 财政年份:
- 资助金额:
$ 4.1万 - 项目类别: